Keyphrases
Atrial Fibrillation
100%
Home Monitoring Devices
64%
Sleep Apnea
64%
Bleeding Risk
64%
Non-interactive
57%
Active Cancer
57%
Lung Cancer
56%
Breast
48%
Cancer Types
38%
Temporal Trends
35%
Hypertension
33%
Confidence Interval
32%
Case-crossover Study
32%
Acute Coronary Syndrome
32%
National Cohort Study
32%
Ischemic Heart Disease
32%
Topical Azoles
32%
Treatment Continuity
32%
Male Patients
32%
Adverse Events
32%
Unselected Patients
32%
Co-prescription
32%
Phosphodiesterase Type 5 Inhibitors
32%
Organic Nitrates
32%
Nitrate
32%
First-line Drugs
32%
Angiotensin Receptor Blockers
32%
Danish National Patient Registry
32%
Thiazides
32%
Oral Glucocorticoids
32%
Register Study
32%
Rivaroxaban
32%
Drug Treatment
32%
Dabigatran
32%
Drug Choice
32%
Gastrointestinal Bleeding
32%
Angiotensin-converting Enzyme Inhibitor (ACEi)
32%
Non-vitamin K Antagonist Oral Anticoagulants
32%
Fluconazole
32%
Apixaban
32%
Colorectal Cancer
32%
Concomitant Treatment
32%
Calcium Channel Blockers
25%
Coronary Angiogram
24%
Gastrointestinal Cancer
24%
Cancer History
24%
Active-active
20%
Absolute Risk
20%
Beta-blockers
19%
Positive Predictive Value
16%
Pharmacology, Toxicology and Pharmaceutical Science
Atrial Fibrillation
100%
Cohort Study
64%
Malignant Neoplasm
64%
Sleep Disordered Breathing
64%
Lung Cancer
37%
Prevalence
36%
Nitric Acid Derivative
32%
Acute Coronary Syndrome
32%
Pyrrole Derivative
32%
Thiazide Diuretic Agent
32%
Glucocorticoid
32%
Ischemic Heart Disease
32%
Dabigatran
32%
Gastrointestinal Hemorrhage
32%
Phosphodiesterase V Inhibitor
32%
Rivaroxaban
32%
Anticoagulant Agent
32%
Colorectal Cancer
32%
Adverse Event
32%
Bleeding
32%
Apixaban
32%
Vitamin K Group
32%
Pharmacotherapy
32%
Dipeptidyl Carboxypeptidase Inhibitor
32%
Patient Registry
32%
Fluconazole
32%
Drug Choice
32%
Organic Nitrate
32%
Angiotensin Receptor Antagonist
32%
Calcium Channel Blocker
25%
Antihypertensive Agent
19%
Beta Adrenergic Receptor Blocking Agent
19%
Pyrrole
7%
Apnea
5%
Digestive System Cancer
5%
Medicine and Dentistry
Atrial Fibrillation
64%
Home Monitoring
64%
Obstructive Sleep Apnea
64%
Malignant Neoplasm
64%
Prevalence
36%
Acute Coronary Syndrome
32%
Ischemic Heart Disease
32%
Patient Registry
32%
Nitric Acid Derivative
32%
Adverse Event
32%
Cancer Types
32%
Cohort Analysis
32%
Colorectal Cancer
32%
Organic Nitrate
32%
Phosphodiesterase V Inhibitor
32%
Cardiorespiratory
11%
Respiratory Monitoring
11%
Cardiovascular System
11%
Odds Ratio
7%
Cancer Diagnosis
6%
Gastrointestinal Cancer
6%
Lung Cancer
6%
Apnea
5%
Hypopnea
5%
